Dr. Sullivan on Targeted Therapy for BRAF-Mutant Melanoma

Hitting the Mark with Targeted Therapy: BRAF, NRAS, CKIT, etc...SullivanПодробнее

Overall Survival Results for Encorafenib Plus Binimetinib in BRAF-Mutant MelanomaПодробнее

Dr. Pavlick on Sequencing Challenges with BRAF-Mutant MelanomaПодробнее

Dr. Sullivan Discusses Role of Dabrafenib Plus Trametinib in MelanomaПодробнее

Dr. Sullivan Discusses the Current Treatment of MelanomaПодробнее

Dr. Ryan Sullivan on Treating BRAF-Mutant Patients With MelanomaПодробнее

Dual-Targeted Therapy for BRAF-Mutant MelanomaПодробнее